Fortress Biotech, Inc.·4

Dec 14, 8:18 PM ET

Avgerinos George 4

4 · Fortress Biotech, Inc. · Filed Dec 14, 2017

Insider Transaction Report

Form 4
Period: 2017-11-29
Avgerinos George
SVP, Biologics Operations
Transactions
  • Sale

    COMMON STOCK, PAR VALUE $0.001

    2017-12-12$3.59/sh25,593$91,879383,495 total
  • Sale

    COMMON STOCK, PAR VALUE $0.001

    2017-12-13$3.57/sh19,000$67,830364,495 total
  • Award

    COMMON STOCK, PAR VALUE $0.001

    2017-11-29+150,000409,088 total
Footnotes (2)
  • [F1]Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015.
  • [F2]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 12, 2017, was $3.53 to $3.72, and the range of prices for the sale transactions on December 13, 2017, was $3.55 to $3.63. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    tv481449_form4.xmlPrimary

    OWNERSHIP DOCUMENT